Home › NDC Lookup › Ingredients › Capsaicin › 00536-1118-25
Rugby Arthritis Pain Relieving Topical Analgesic Capsaicin .75 mg/g Cream — NDC 00536-1118-25 package photo

Rugby Arthritis Pain Relieving Topical Analgesic Capsaicin .75 mg/g Cream

by Rugby Laboratories · 1 TUBE in 1 CARTON (0536-1118-25) / 57 g in 1 TUBE
NDC 00536-1118-25
🏷️ FDA NDC (as labeled) 0536-1118-25 billing pads the labeler segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 0536-1118-25
Product NDC 0536-1118
11-digit billing NDC 00536111825
NCPDP billing unit GM — per gram (weight)
RxCUI 141868
UNII S07O44R1ZM
Application # M017
SPL Set ID 8f1bc075-97ac-4154-8768-0d878104c3ba
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2017-05-24
Route TOPICAL
Dosage form CREAM
Substance CAPSAICIN
GPI-14 90850025003730
GPI class Arthritis Pain Relieving
GCN Seq No 012072
GCN 33561
HICL code 002577
Ingredient (HICL) Capsaicin
HIC1 code L
Therapeutic class — broad (HIC1) Skin/Subcutaneous Tissue
HIC2 code L6
Therapeutic class — intermediate (HIC2) Irritants
HIC3 code L6A
Therapeutic class — specific (HIC3) Irritants/Counter-Irritants
AHFS code 84:92.00.00
AHFS class Skin And Mucous Membrane Agents, Misc.
FDB label name ARTHRITIS PAIN RLF 0.075% CRM
FDB brand name Arthritis Pain Relieving
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 0536-1118-25 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00536-1118-25. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Capsaicin and similar agents class.

Drug family (ATC) Capsaicin and similar agents, Other local anesthetics
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerRugby Laboratories
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code00536
First marketedMay 2017
Product typeHuman Otc Drug
Portfolio149 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name ARTHRITIS PAIN RLF 0.075% CRM Ingredient Capsaicin
📖 What it is MedlinePlus · NLM

Topical capsaicin is used to relieve minor pain in muscles and joints caused by arthritis, backaches, muscle strains, bruises, cramps, and sprains. Capsaicin is a substance that is found in chili peppers. It works by affecting nerve cells in the skin that are associated with pain, which results in decreased activity of these nerve cells and a reduced sense of pain.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Yes, completely normal — and it actually means the medicine is working. Capsaicin activates the same pain-sensing receptors in your skin that respond to heat and spicy food. That b...
  • Why does capsaicin burn when I put it on? Is that normal?
  • For most OTC creams and ointments, you can apply up to 3 to 4 times a day. For OTC patches, apply to clean, dry skin and remove after no more than 8 hours — again, up to 3 to 4 tim...
  • How often should I apply capsaicin cream or use the patch?
📖 Read our full Capsaicin guide →

Supplement & herbal interactions

Some supplements/herbs that may interact with Capsaicin (prescription drug) — tap one for details:

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color white
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII LKG8494WBH
    Benzyl alcohol is a clear liquid used as a preservative and solvent in medicines. It helps prevent bacterial and fungal growth and dissolves other ingredients to create uniform liquid formulations.
  • UNII 936JST6JCN
    Cetyl alcohol is a waxy, fatty substance derived from plant or animal sources. It acts as an emulsifier and thickener in medicines, helping blend oil and water components and giving products a smooth, creamy texture.
  • UNII 230OU9XXE4
    A waxy substance made from glycerin and stearic acid that acts as an emulsifier to blend oily and watery ingredients together. It also helps thicken and stabilize the medicine's texture.
  • UNII 0RE8K4LNJS
    Isopropyl myristate is an oily liquid made from coconut or palm oil. It's used in medicines as an emollient and penetration enhancer to help the medicine absorb through skin or improve spreadability in topical products.
  • UNII YD01N1999R
    A waxy substance made from polyethylene glycol and stearic acid. It helps mix oil and water-based ingredients together and serves as an emulsifier and solubilizer in liquid and semi-solid medicines.
  • UNII 4T6H12BN9U
    Petrolatum is a purified mineral oil-based jelly derived from petroleum. In medicines, it acts as an emollient, lubricant, and moisture barrier to soften skin, reduce friction, and help prevent water loss from formulations.
  • UNII 506T60A25R
    Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

8 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesbenzyl alcohol, cetyl alcohol, glyceryl stearate, isopropyl myristate, PEG-100 stearate, petrolatum, sorbitol, water

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.071 $4.06 / 57 g
Medicaid paysCMS SDUD · 12 mo $0.2651 $15.11 / 57 g
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Oct 2021 Dec 2023 Mar 2026 Sep 2026 $0.082 $0.069
▼ Down 6% over the last 18 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Rugby Arthritis Pain Relieving Topical Analgesic .75 mg/gthis 00536-1118-25 Rugby 1 tube $0.071 — Availability likely —
Capsaicin Topical Analgesic .75 mg/g 50268-0196-57 AvPAK 1 tube $0.071 — Availability likely —
Sheffield Arthritis and Muscle Pain Relief .075 g/100g 11527-0080-60 Sheffield 1 tube — — FDA listed —
AVON HeXashield Arthritis Pain Relief Cream Capsaisin .75 mg/g 43136-0101-01 Tai 1 tube — — FDA listed —
Capsaicin 0.075 Percent .075 g/100g 50488-1075-06 Alexso, 120 g — — FDA listed —
Capsaicin Cream 0.075% .075 g/100g 73492-0271-60 ALAINA 1 tube — — FDA listed —
Capsaicin 0.075% Cream .075 g/100g 85231-0202-60 ViolaCare, 1 tube — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2017
On the market since
May 2017
📍
2026
Currently FDA-listed
9 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 00536-1118-25, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
7.2K
Units reimbursed last 4 qtrs
461.6K
Gross reimbursed last 4 qtrs
$122.4K
Avg / prescription
$16.98
Avg / unit
$0.2651
Latest quarter Q4 2025
1.7KRx
Medicaid pays / g
$0.2651
gross reimbursed
vs
NADAC / g
$0.0713
acquisition cost
=
Spread
+$0.1938
+272% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
54% FFS 46% MCO
Fee-for-service · 3,927 Rx Managed care · 3,280 Rx
State Medicaid map
Alaska: no data reported AK Maine: 5,700 units · 409 per 100k residents ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 50,791 units · 885 per 100k residents MN Wisconsin: 34,829 units · 589 per 100k residents WI Michigan: no data reported MI New York: 112,030 units · 572 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 9,009 units · 213 per 100k residents OR Nevada: 3,606 units · 113 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 8,835 units · 70.4 per 100k residents IL Indiana: 9,304 units · 136 per 100k residents IN Ohio: 66,150 units · 561 per 100k residents OH Pennsylvania: 51,753 units · 399 per 100k residents PA New Jersey: 16,528 units · 178 per 100k residents NJ Massachusetts: 30,243 units · 432 per 100k residents MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 4,275 units · 216 per 100k residents NE Missouri: no data reported MO Kentucky: 12 units · 0.3 per 100k residents KY West Virginia: no data reported WV Virginia: 12,888 units · 148 per 100k residents VA Maryland: no data reported MD Connecticut: 30,210 units · 835 per 100k residents CT Rhode Island: 2,109 units · 193 per 100k residents RI Arizona: 6,159 units · 82.9 per 100k residents AZ New Mexico: 4,504 units · 213 per 100k residents NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: 1,619 units · 238 per 100k residents DC Hawaii: 1,086 units · 75.7 per 100k residents HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
0.3885
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Minnesota 885 /100k
2 Connecticut 835 /100k
3 Wisconsin 589 /100k
4 New York 572 /100k
5 Ohio 561 /100k
6 Massachusetts 432 /100k
7 Maine 409 /100k
8 Pennsylvania 399 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Rugby Arthritis Pain Relieving Topical Analgesic (this brand).

Top reported reactions

Fatigue141
Weight Increased99
Pain91
Insomnia89
Poor Quality Sleep75
Hypertension71
Cataract68

Age at onset

Child2
Adolescent4
Adult140
Elderly79

Reporter sex

1,399 reports

Serious outcomes

Disabling76
Life-threatening56
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 123 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
00536-1118-25 You're viewing this 1 TUBE in 1 CARTON (0536-1118-25) / 57 g in 1 TUBE 2017-05-24 Active

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 18 words ▾

Uses temporarily relieves minor aches and pains of muscles and joints due to: simple backache arthritis strains sprains

⏱️ Dosage and Administration 55 words ▾

Directions Adults and children 18 years of age and older: apply a thin film of cream to affected area and gently rub in until fully absorbed unless treating hands, wash hands thoroughly with soap and water immediately after application for best results, apply 3 to 4 times daily. Children under 18 years: ask a doctor

⚠️ Warnings 151 words ▾

Warnings For external use only Read all warnings and directions before use. TEST FIRST ON SMALL AREA OF SKIN. Do not use on wounds or damaged skin if you are allergic to capsicum or chili peppers When using this product you may experience a burning sensation.

The intensity of this reaction varies among individuals and may be severe. With regular use, this sensation generally disappears after several days. avoid contact with eyes, lips, nose and mucous membranes do not tightly wrap or bandage the treated area do not apply heat to the treated area immediately before or after use Stop and ask a doctor if condition worsens or does not improve after regular use severe burning persists or blistering occurs Keep out of reach of children . If swallowed, get medical help or contact a Poison Control Center immediately.

If pregnant or breast feeding , ask a health professional before use.

📦 Storage and Handling 12 words ▾

Other information Store at room temperature 15° - 30°C (59°F – 86°F).

🧪 Active Ingredient 4 words ▾

Active ingredient Capsaicin 0.075%

🧪 Inactive Ingredients 15 words ▾

Inactive ingredients benzyl alcohol, cetyl alcohol, glyceryl stearate, isopropyl myristate, PEG-100 stearate, petrolatum, sorbitol, water

🎯 Purpose 3 words ▾

Purpose Topical Analgesic

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.